Milestones in the Treatment of malignant Melanoma Nivolumab in the Adjuvant and as a Combination Therapy with Ipilimumab in Patients with advanced Melanoma

被引：0
|
作者：
Sankawa, Yuri
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷 / 7-8期
关键词：
STAGE-III MELANOMA; SURVIVAL;
D O I：
10.1159/000502188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [1] Nivolumab and ipilimumab therapy for advanced melanoma
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2013, 14 (08): : E298 - E298
  • [2] Nivolumab in combination with ipilimumab for the treatment of melanoma
    Somasundaram, Rajasekharan
    Herlyn, Meenhard
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1135 - 1141
  • [3] Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma
    Takahashi, Akira
    Namikawa, Kenjiro
    Ogata, Dai
    Jinnai, Shunichi
    Nakano, Eiji
    Yamazaki, Naoya
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (04): : 525 - 535
  • [4] COST EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN ENGLAND
    Lee, D.
    Amadi, A.
    Sabater, J.
    Ellis, J.
    Johnson, H.
    Roskell, N.
    Meng, Y.
    Patterson, K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A731 - A731
  • [5] Nico: Real World Evidence in Advanced Melanoma; A National Prospective Non-Interventional Study of Nivolumab Monotherapy or in Combination with Ipilimumab in Patients with Advanced Melanoma and in Patients with Adjuvant Nivolumab Therapy
    Schadendorf, Dirk
    Eigertler, Thomas
    Mohr, Peter
    Weichenthal, Michael
    Goeppner, Daniela
    Haferkamp, Sebastian
    Herber, Martin
    Meier, Friedegund
    Meiss, Frank
    Pfoehler, Claudia
    Schneider, Stefan W.
    Terheyden, Patrick
    Ulrich, Lens
    Utikal, Jochen
    Weishaupt, Carsten
    Gutzmer, Ralf
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 175 - 175
  • [6] Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma
    Carreau, Nicole A.
    Pavlick, Anna C.
    [J]. FUTURE ONCOLOGY, 2019, 15 (04) : 349 - 358
  • [7] Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
    Sznol, Mario
    Ferrucci, Pier Francesco
    Hogg, David
    Atkins, Michael B.
    Wolter, Pascal
    Guidoboni, Massimo
    Lebbe, Celeste
    Kirkwood, John M.
    Schachter, Jacob
    Daniels, Gregory A.
    Hassel, Jessica
    Cebon, Jonathan
    Gerritsen, Winald
    Atkinson, Victoria
    Thomas, Luc
    McCaffrey, John
    Power, Derek
    Walker, Dana
    Bhore, Rafia
    Jiang, Joel
    Hodi, F. Stephen
    Wolchok, Jedd D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3815 - +
  • [8] Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma
    Tetu, Pauline
    Mangana, Joanna
    Dummer, Reinhard
    Dutriaux, Caroline
    Beneton, Nathalie
    Dalle, Stephane
    Meyer, Nicolas
    Oriano, Bastien
    Michielin, Olivier
    Lebbe, Celeste
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 93 : 147 - 149
  • [9] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Tsai, Katy K.
    Daud, Adil I.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [10] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Katy K. Tsai
    Adil I. Daud
    [J]. Journal of Hematology & Oncology, 8
12345